Eli Lilly's (LLY) new weight-loss drug could generate more than $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000.
Eli Lily stock and the road to 1000
版主： Nimitz
版主： Nimitz
Eli Lilly's (LLY) new weight-loss drug could generate more than $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000.
百升飞上天，明月照长安。
